Talking Tumors: MSK Faculty Highlight Ovarian Cancer Cases

Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, discuss two common clinical scenarios faced in practice, and the data to support their approaches.

We recently traveled to New York City, New York, for a State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma. In keeping up with the constant and sometimes controversial landscape of ovarian cancer, we sat down with Mario M. Leitao Jr, MD, FACOG, FACS, and Dmitriy Zamarin, MD, PhD, of Memorial Sloan Kettering Cancer Center, to discuss two common clinical scenarios faced in practice, and the data to support their approaches.